Candel Therapeutics, Inc.
corporate_fare Company Profile
Candel Therapeutics, Inc. (NASDAQ:CADL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for CADL at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Director Paul Manning Buys Nearly $3M in Candel Therapeutics Stock
- Candel Therapeutics Formalizes $100M Public Offering, Extends Cash Runway to Q1 2028
- Candel Therapeutics Finalizes $100M Public Offering, Extending Cash Runway for Key Programs
- Candel Therapeutics Announces $100 Million Common Stock Offering, Extending Cash Runway to Q1 2028
- Candel Therapeutics Secures $100M Royalty Funding from RTW for CAN-2409 Prostate Cancer Launch
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$38.18M
Diluted EPS
-$0.72
Op. Cash Flow
-$38.31M
Free Cash Flow
-$38.9M
Operating Income
-$48.27M
Cash & Equivalents
$119.73M
Total Debt
$46.12M
Debt / Equity
0.89×
Shares Outstanding
54.9M sh
Source: 10-K · filed 2026-03-12 · accession 0001193125-26-103134
show_chartPrice Chart
Loading chart...
feed CADL - Filings & News (Page 2)
CADL
Feb 26, 2026, 7:38 PM EST
Price at Filing:
$5.69
Real-time Price:
$4.99
Change:
-$0.6975 (-12%)
Market Cap:
$395.368M
CADL
Feb 23, 2026, 8:00 AM EST
Price at Filing:
$5.10
Real-time Price:
$4.99
Change:
-$0.1088 (-2%)
Market Cap:
$395.368M
CADL
Feb 20, 2026, 4:16 PM EST
Price at Filing:
$5.07
Real-time Price:
$4.99
Change:
-$0.0787 (-2%)
Market Cap:
$395.368M
CADL
Feb 19, 2026, 4:31 PM EST
Price at Filing:
$5.46
Real-time Price:
$4.99
Change:
-$0.4688 (-9%)
Market Cap:
$395.368M
CADL
Feb 19, 2026, 4:03 PM EST
Price at Filing:
$6.15
Real-time Price:
$4.99
Change:
-$1.16 (-19%)
Market Cap:
$395.368M